Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

1.7K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Integrating imaging techniques to enhance precision in cancer immunotherapy.

Frontiers in oncology·2026
Same author

Pituitary adenoma imaging as a determinant of acromegaly diagnosis and outcomes.

The Journal of clinical endocrinology and metabolism·2026
Same author

Overcoming the detection limit of GMR sensors using disk-shaped nanostructures.

Talanta·2026
Same author

Specific Reduction of Dopaminergic Fiber Input to Ventrobasal Forebrain Targets in Neonatal Mice Following Prenatal Exposure to Valproate.

Biomedicines·2026
Same author

[Consequences of congenital COVID-19 on the cognitive development of affected children].

Medicina·2026
Same author

Chaperone mediated autophagy is deficient in spinal motoneurons of ALS patients with TDP-43 proteinopathy.

Acta neuropathologica communications·2026
Same journal

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Endothelial injury with capillary leak: A final common pathway in acute AAV toxicity?

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Long-term functional synaptic integration of genome-edited retinal organoids in a primate model of macular degeneration.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Nox1/4 inhibitor Setanaxib treatment ameliorates cardiac function in mouse models of Duchenne Muscular Dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

HSP90α-USP7-DNMT1 Axis Drives Hepatocellular Carcinoma Recurrence After Microwave Ablation by Disrupting ACSS3-Mediated Propionate Metabolism.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

Efficient Differentiation of Mouse Embryonic Stem Cells into Motor Neurons
09:42

Efficient Differentiation of Mouse Embryonic Stem Cells into Motor Neurons

Published on: June 9, 2012

21.8K

Mesenchymal stem cells improve motor functions and decrease neurodegeneration in ataxic mice.

Jonathan Jones1, Alicia Estirado1, Carolina Redondo1

  • 1Neuroscience Institute, University Miguel Hernández (UMH-CSIC), San Juan, Alicante, Spain.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|July 30, 2014
PubMed
Summary
This summary is machine-generated.

Bone marrow stem cells show promise for treating Friedreich

More Related Videos

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

995
A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

35.3K

Related Experiment Videos

Last Updated: Apr 26, 2026

Efficient Differentiation of Mouse Embryonic Stem Cells into Motor Neurons
09:42

Efficient Differentiation of Mouse Embryonic Stem Cells into Motor Neurons

Published on: June 9, 2012

21.8K
A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease
05:39

A Fine Motor Task to Study Joint Kinematics in a Preclinical Model of Neurodegenerative Disease

Published on: June 13, 2025

995
A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

35.3K

Area of Science:

  • Neuroscience
  • Stem Cell Biology
  • Genetics

Background:

  • Friedreich's ataxia is a neurodegenerative disorder characterized by dorsal root ganglia degeneration.
  • Mesenchymal stem cells (MSCs) are being investigated for their therapeutic potential.

Purpose of the Study:

  • To evaluate the feasibility of using bone marrow-derived MSCs for treating Friedreich's ataxia.
  • To assess the impact of MSC transplantation on motor skills and neuronal survival in a mouse model.

Main Methods:

  • Intrathecal injection of MSCs from wild-type or YG8 mice into YG8 mice.
  • Assessment of motor skills, frataxin expression, apoptotic markers, trophic factors, and antioxidant enzymes.

Main Results:

  • Both MSC groups showed improved motor skills and increased frataxin expression.
  • Reduced apoptosis and increased expression of trophic factors (NT3, NT4, BDNF) and antioxidant enzymes (catalase, GPX-1) were observed.
  • No significant difference between wild-type and YG8-derived MSCs.

Conclusions:

  • Bone marrow MSC transplantation is a feasible therapeutic strategy for Friedreich's ataxia.
  • Autologous and allogeneic MSCs can delay neurodegeneration in the dorsal root ganglia.